Iaso Bio

Provider of pharmaceuticals for cell therapies for oncology

placeNanjing, Jiangsu, China calendar_todayFounded 2017 groups400 employees language iasobio.com

Registered entities

Social engagement

Social engagement: 2.5K social following, 10 posts in the last 12 months — above the industry median.

Investor mix

15 investors on record; lead investors include Hillhouse, Shanghai Guoxin Investment Development, Efung Capital, Hongcheng Capital.

Investor typeCountShare
Venture capital320%
Private equity533%
Bank & private debt213%
Other / undisclosed533%

Recent activity

18 Jun 2026
Milestone
regulatory
10 Apr 2026
Partnership
Instituto Butantan
29 Oct 2025
Partnership
GC Cell
Coming soon